Change in echocardiography in patients with transthyretin amyloid cardiomyopathy with tafamidis treatment.
Presentation
Correlations between pathological deposition and non-invasive diagnostic modalities like 99mTc-PYP scintigraphy, cardiac magnetic resonance, GLS in patients with transthyretin cardiac amyloidosis.
